Pliant Therapeutics, Inc(NASDAQ:PLRX) 
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of av6 and ...
Website: http://www.pliantrx.com
Founded: 2015
Full Time Employees: 70
CEO: Bernard Coulie
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.26
H 1.35
L 1.24
C 1.34
V 1,412,082
10EMA 1.34
20EMA 1.34
60EMA 1.34
120EMA 1.34
250EMA 1.34